Navigation Links
Ventria Expands Team and Hires Kansan as Director of Bioprocessing Operations

JUNCTION CITY, Kan., Jan. 9 /PRNewswire/ -- Ventria Bioscience announced today that Angus Connell would be joining the company as Director of Bioprocessing Operations for the company's Junction City facility.

Connell, a Kansas native, has extensive experience in operations, engineering design and process development leadership with Koch Industries and Coffeyville Resources. At Koch Industries, he held positions including Manager of Process Engineering and Director of Engineering and Research. He was most recently the Operations Manager for Coffeyville Resources. Angus received his Bachelor of Science degree in Chemical Engineering from the University of Tulsa.

"Angus brings a wealth of process engineering, operations management, and plant expansion capabilities to our team in Junction City," said Greg Unruh, Vice President and General Manager, Ventria Bioscience. "His experience is vital as we continue with the expansion of our facility. We are continually searching for talented employees with engineering, biology and agronomy experience to fill open positions in our Kansas operations. Many of the candidates we have hired in the last year have been trained by Kansas State University, University of Kansas, McPherson College and other Kansas-based educational institutions. Many are Kansas natives, like Angus, who are looking for the opportunity to become part of the bioscience industry in their home state of Kansas," he said.

"I am quite happy for the opportunity to remain in Kansas, at the same time I get to work in a cutting edge industry where I can continue to learn. My other opportunities would have required me to leave Kansas in order to advance my career," said Connell.

About Ventria

A recent child health study showed that Ventria's Lactiva and Lysomin helped reduce the duration of diarrhea in children by 30 percent when added to rehydration solutions. Childhood diarrhea is the second leading killer of children, claiming 2 million lives annually according to the World Health Organization.

For more information, see our website:

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.

SOURCE Ventria Bioscience
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Science Teachers Tour Ventrias Bioprocessing Facility
2. Symmetry Medical Expands Board of Directors
3. UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGos Platform
4. Observant LLC Expands Senior Management Team
5. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
6. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
7. CSL Behring Expands Into Middle East Market with Haemate(R) P
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
10. Siemens Expands the SOMATOM Definition(TM) Line With Worlds First Adaptive CT Scanner
11. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
Post Your Comments:
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT ... care circle with the physician and clinical trial team. , Using the CONSULT module, ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
Breaking Biology News(10 mins):